NasdaqCM - Delayed Quote USD

Envoy Medical, Inc. (COCH)

5.18 +0.11 (+2.17%)
At close: April 26 at 4:00 PM EDT
Key Events
Loading Chart for COCH
DELL
  • Previous Close 5.07
  • Open 5.05
  • Bid 5.05 x 100
  • Ask 5.32 x 100
  • Day's Range 4.98 - 5.42
  • 52 Week Range 0.75 - 11.72
  • Volume 59,438
  • Avg. Volume 440,828
  • Market Cap (intraday) 101.528M
  • Beta (5Y Monthly) 2.66
  • PE Ratio (TTM) --
  • EPS (TTM) -2.38
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 5.00

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

www.envoymedical.com

34

Full Time Employees

December 31

Fiscal Year Ends

Recent News: COCH

Performance Overview: COCH

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

COCH
186.03%
S&P 500
6.92%

1-Year Return

COCH
48.30%
S&P 500
25.26%

3-Year Return

COCH
--
S&P 500
21.10%

5-Year Return

COCH
--
S&P 500
21.10%

Compare To: COCH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COCH

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    101.53M

  • Enterprise Value

    97.87M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    205.77

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    309.72

  • Enterprise Value/EBITDA

    -5.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -225.22%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    316k

  • Net Income Avi to Common (ttm)

    -29.91M

  • Diluted EPS (ttm)

    -2.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.22M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -6.54M

Research Analysis: COCH

Analyst Price Targets

4.00 Low
5.00 Average
5.18 Current
6.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: COCH

Fair Value

5.18 Current
 

Dividend Score

0 Low
COCH
Sector Avg.
100 High
 

Hiring Score

0 Low
COCH
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
COCH
Sector Avg.
100 High
 

People Also Watch